Brandinium

Trademark search for:

GLUCLIPSE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2010-09-01 — Application filed
  • 2010-09-04 — Application filed
  • 2010-09-06 — Application filed
  • 2010-11-29 — Assigned to examiner
  • 2010-11-30 — Priority action written
  • 2010-11-30 — Priority action mailed
  • 2011-04-04 — Office action issued
  • 2011-04-04 — Correspondence received in law office
  • 2011-04-04 — Teas/email correspondence entered
  • 2011-04-06 — Examiners amendment -written
  • 2011-04-06 — Examiner's amendment entered
  • 2011-04-07 — Examiners amendment mailed
  • 2011-04-07 — Approved for pub - principal register
  • 2011-04-19 — Teas revoke/app/change addr of atty/dom rep received
  • 2011-04-19 — Attorney/dom.rep.revoked and/or appointed
  • 2011-04-22 — Assigned to lie
  • 2011-04-22 — Law office publication review completed
  • 2011-05-11 — Notice of publication
  • 2011-05-31 — Published for opposition
  • 2011-07-26 — Noa mailed - sou required from applicant
  • 2011-12-22 — Sou teas extension received
  • 2011-12-22 — Sou extension 1 filed
  • 2012-01-25 — Case assigned to intent to use paralegal
  • 2012-01-25 — Sou extension 1 granted
  • 2012-01-26 — Notice of approval of extension request mailed
  • 2012-06-26 — Sou teas extension received
  • 2012-06-26 — Sou extension 2 filed
  • 2012-06-29 — Sou extension 2 granted
  • 2012-06-30 — Notice of approval of extension request mailed
  • 2013-01-10 — Sou teas extension received
  • 2013-01-10 — Sou extension 3 filed
  • 2013-01-15 — Sou extension 3 granted
  • 2013-01-16 — Notice of approval of extension request mailed
  • 2013-03-12 — Teas change of correspondence received
  • 2013-07-01 — Sou teas extension received
  • 2013-07-01 — Sou extension 4 filed
  • 2013-07-05 — Sou extension 4 granted
  • 2013-07-06 — Notice of approval of extension request e-mailed
  • 2014-01-24 — Sou teas extension received
  • 2014-01-24 — Sou extension 5 filed
  • 2014-01-31 — Sou extension 5 granted
  • 2014-02-01 — Notice of approval of extension request e-mailed
  • 2014-03-18 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-03-18 — Attorney/dom.rep.revoked and/or appointed
  • 2014-03-19 — Automatic update of assignment of ownership
  • 2014-09-01 — Application abandoned
  • 2014-09-01 — Final status recorded
  • 2014-09-02 — Application abandoned
  • 2014-10-08 — Assignment of ownership not updated automatically

Owner Information

ASTRAZENECA AB
SODERTALJE SE
Bristol-Myers Squibb Company
New York , NY
Bristol-Myers Squibb Company
New York , NY

Correspondent

Marc Stanislawczyk AstraZeneca Pharmaceuticals LLP
1800 Concord Pike
FOP3-022
Wilmington, DE 19850-5437

Filing Details

Filing Date:
2010-09-01
Status Date:
2014-09-01
Category:
Pharmaceuticals
Filing Year:
2006

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.